|
nombre  pulsa para comparar los precios |
Compremos local, ética y al mejor precio sobre Ethishop  |
|
|
Evaluación « ética » de Boehringer
, grupo
y filiales
|
Fraude 1
Paraíso 1
Influencia 4
| [haga clic sobre las imágenes abajo o sobre ayudo para más información]
|
|
Accionista
Actividad & mercado
Sitios de fabricación
año | delincuencia financiera | | | activo | | fuente |
2005 |
Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. traducir |
| | | |   | | Canadian Press |
1998 |
| | | 7,1 |   | mil milliones US$ | Forbes |
|
año | delincuencia financiera | ventas | resultado | activo | recompra | fuente |
|
|
|